nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—ABCG2—Zafirlukast—asthma	0.0913	0.177	CbGbCtD
Leflunomide—CYP1A2—Zileuton—asthma	0.0428	0.0831	CbGbCtD
Leflunomide—CYP2C9—Zileuton—asthma	0.0385	0.0749	CbGbCtD
Leflunomide—CYP1A2—Zafirlukast—asthma	0.0376	0.0732	CbGbCtD
Leflunomide—ABCG2—Hydrocortisone—asthma	0.0372	0.0723	CbGbCtD
Leflunomide—CYP2C9—Zafirlukast—asthma	0.0339	0.0659	CbGbCtD
Leflunomide—CYP2C9—Arformoterol—asthma	0.0328	0.0637	CbGbCtD
Leflunomide—CYP2C9—Formoterol—asthma	0.0328	0.0637	CbGbCtD
Leflunomide—CYP1A2—Aminophylline—asthma	0.0309	0.0601	CbGbCtD
Leflunomide—CYP1A2—Theophylline—asthma	0.0291	0.0565	CbGbCtD
Leflunomide—CYP2C9—Theophylline—asthma	0.0262	0.0509	CbGbCtD
Leflunomide—CYP2C9—Loratadine—asthma	0.0248	0.0483	CbGbCtD
Leflunomide—CYP2C9—Montelukast—asthma	0.0248	0.0483	CbGbCtD
Leflunomide—ABCG2—Dexamethasone—asthma	0.0231	0.0449	CbGbCtD
Leflunomide—CYP2C9—Dexamethasone—asthma	0.00859	0.0167	CbGbCtD
Leflunomide—Niflumic Acid—PLA2G4A—asthma	0.00435	0.828	CrCbGaD
Leflunomide—PTK2B—respiratory system—asthma	0.0036	0.0962	CbGeAlD
Leflunomide—DHODH—adrenal gland—asthma	0.00344	0.092	CbGeAlD
Leflunomide—PTK2B—Pindolol—Isoprenaline—asthma	0.00327	1	CbGdCrCtD
Leflunomide—DHODH—lung—asthma	0.00302	0.0806	CbGeAlD
Leflunomide—PTK2B—smooth muscle tissue—asthma	0.0029	0.0775	CbGeAlD
Leflunomide—PTK2B—cardiovascular system—asthma	0.00276	0.0737	CbGeAlD
Leflunomide—AHR—adrenal cortex—asthma	0.00248	0.0664	CbGeAlD
Leflunomide—AHR—bronchus—asthma	0.00244	0.0651	CbGeAlD
Leflunomide—AHR—smooth muscle tissue—asthma	0.00238	0.0637	CbGeAlD
Leflunomide—AHR—trachea—asthma	0.00219	0.0584	CbGeAlD
Leflunomide—PTK2B—adrenal gland—asthma	0.00218	0.0583	CbGeAlD
Leflunomide—PTK2B—lung—asthma	0.00191	0.0511	CbGeAlD
Leflunomide—AHR—adrenal gland—asthma	0.00179	0.0479	CbGeAlD
Leflunomide—AHR—lung—asthma	0.00157	0.042	CbGeAlD
Leflunomide—CYP1A2—respiratory system—asthma	0.00111	0.0295	CbGeAlD
Leflunomide—ABCG2—adrenal cortex—asthma	0.000964	0.0257	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—asthma	0.000908	0.173	CrCbGaD
Leflunomide—CYP2C9—cardiovascular system—asthma	0.000803	0.0215	CbGeAlD
Leflunomide—ABCG2—adrenal gland—asthma	0.000696	0.0186	CbGeAlD
Leflunomide—ABCG2—lung—asthma	0.00061	0.0163	CbGeAlD
Leflunomide—CYP1A2—lung—asthma	0.000587	0.0157	CbGeAlD
Leflunomide—PTK2B—Signaling Pathways—CCR8—asthma	7.41e-05	0.000719	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL17—asthma	7.27e-05	0.000705	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—asthma	7.2e-05	0.000698	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—asthma	7.19e-05	0.000697	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—asthma	7.16e-05	0.000695	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LTC4S—asthma	7.11e-05	0.00069	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—POMC—asthma	7.03e-05	0.000682	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR3—asthma	7.03e-05	0.000682	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GSTM1—asthma	6.94e-05	0.000674	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—asthma	6.86e-05	0.000665	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—ALDH2—asthma	6.7e-05	0.00065	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—asthma	6.66e-05	0.000647	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—asthma	6.57e-05	0.000638	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDE4A—asthma	6.48e-05	0.000629	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—KIF3A—asthma	6.48e-05	0.000629	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ALB—asthma	6.41e-05	0.000622	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTT1—asthma	6.37e-05	0.000619	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	6.32e-05	0.000614	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LTC4S—asthma	6.27e-05	0.000609	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1RN—asthma	6.25e-05	0.000607	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CYBA—asthma	6.25e-05	0.000607	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	6.17e-05	0.000598	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—asthma	6.15e-05	0.000597	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NOS3—asthma	6.13e-05	0.000595	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL5—asthma	6.12e-05	0.000594	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—asthma	6.12e-05	0.000594	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—asthma	6.09e-05	0.000591	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LTC4S—asthma	6.08e-05	0.00059	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DPB1—asthma	6.07e-05	0.000589	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CYSLTR1—asthma	6.07e-05	0.000589	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—STAT3—asthma	6.03e-05	0.000585	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—CARM1—asthma	5.91e-05	0.000574	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VIP—asthma	5.86e-05	0.000569	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—UTS2—asthma	5.86e-05	0.000569	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL11—asthma	5.86e-05	0.000569	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CMA1—asthma	5.86e-05	0.000569	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—C5AR1—asthma	5.86e-05	0.000569	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD40—asthma	5.84e-05	0.000567	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR2—asthma	5.84e-05	0.000567	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTLA4—asthma	5.76e-05	0.000558	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ADCY2—asthma	5.71e-05	0.000555	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL3—asthma	5.69e-05	0.000553	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR4—asthma	5.62e-05	0.000545	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGS2—asthma	5.61e-05	0.000544	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT6—asthma	5.51e-05	0.000535	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD79A—asthma	5.49e-05	0.000533	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LTA4H—asthma	5.44e-05	0.000528	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2RB—asthma	5.41e-05	0.000525	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—asthma	5.4e-05	0.000524	CbGpPWpGaD
Leflunomide—Arrhythmia—Dexamethasone—asthma	5.37e-05	0.00016	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PDE4D—asthma	5.36e-05	0.00052	CbGpPWpGaD
Leflunomide—Ill-defined disorder—Triamcinolone—asthma	5.35e-05	0.000159	CcSEcCtD
Leflunomide—Ill-defined disorder—Methylprednisolone—asthma	5.34e-05	0.000159	CcSEcCtD
Leflunomide—Alopecia—Dexamethasone—asthma	5.31e-05	0.000158	CcSEcCtD
Leflunomide—Alopecia—Betamethasone—asthma	5.31e-05	0.000158	CcSEcCtD
Leflunomide—Nausea—Salbutamol—asthma	5.3e-05	0.000157	CcSEcCtD
Leflunomide—Hypertension—Hydrocortisone—asthma	5.29e-05	0.000157	CcSEcCtD
Leflunomide—Discomfort—Prednisolone—asthma	5.28e-05	0.000157	CcSEcCtD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—asthma	5.27e-05	0.000511	CbGpPWpGaD
Leflunomide—Angioedema—Triamcinolone—asthma	5.27e-05	0.000157	CcSEcCtD
Leflunomide—PTK2B—Immune System—CD14—asthma	5.26e-05	0.000511	CbGpPWpGaD
Leflunomide—Haemoglobin—Prednisone—asthma	5.26e-05	0.000156	CcSEcCtD
Leflunomide—Angioedema—Methylprednisolone—asthma	5.26e-05	0.000156	CcSEcCtD
Leflunomide—Haemorrhage—Prednisone—asthma	5.24e-05	0.000156	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—C5—asthma	5.22e-05	0.000507	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TACR1—asthma	5.22e-05	0.000507	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDE4B—asthma	5.22e-05	0.000507	CbGpPWpGaD
Leflunomide—Myalgia—Hydrocortisone—asthma	5.21e-05	0.000155	CcSEcCtD
Leflunomide—Malaise—Triamcinolone—asthma	5.2e-05	0.000154	CcSEcCtD
Leflunomide—Anxiety—Hydrocortisone—asthma	5.2e-05	0.000154	CcSEcCtD
Leflunomide—Malaise—Methylprednisolone—asthma	5.19e-05	0.000154	CcSEcCtD
Leflunomide—Vertigo—Triamcinolone—asthma	5.18e-05	0.000154	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—asthma	5.18e-05	0.000503	CbGpPWpGaD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.18e-05	0.000154	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—GSTP1—asthma	5.17e-05	0.000502	CbGpPWpGaD
Leflunomide—Vertigo—Methylprednisolone—asthma	5.17e-05	0.000154	CcSEcCtD
Leflunomide—Discomfort—Hydrocortisone—asthma	5.15e-05	0.000153	CcSEcCtD
Leflunomide—Connective tissue disorder—Prednisone—asthma	5.14e-05	0.000153	CcSEcCtD
Leflunomide—Nausea—Budesonide—asthma	5.13e-05	0.000153	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisolone—asthma	5.12e-05	0.000152	CcSEcCtD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTP1—asthma	5.1e-05	0.000495	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—VCAM1—asthma	5.08e-05	0.000493	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DQA1—asthma	5.07e-05	0.000492	CbGpPWpGaD
Leflunomide—Cough—Triamcinolone—asthma	5.03e-05	0.000149	CcSEcCtD
Leflunomide—Anaphylactic shock—Hydrocortisone—asthma	5e-05	0.000148	CcSEcCtD
Leflunomide—Tachycardia—Prednisolone—asthma	5e-05	0.000148	CcSEcCtD
Leflunomide—Hypertension—Triamcinolone—asthma	4.98e-05	0.000148	CcSEcCtD
Leflunomide—Hypertension—Methylprednisolone—asthma	4.97e-05	0.000148	CcSEcCtD
Leflunomide—Infection—Hydrocortisone—asthma	4.97e-05	0.000148	CcSEcCtD
Leflunomide—Hyperhidrosis—Prednisolone—asthma	4.95e-05	0.000147	CcSEcCtD
Leflunomide—Myalgia—Triamcinolone—asthma	4.91e-05	0.000146	CcSEcCtD
Leflunomide—Nervous system disorder—Hydrocortisone—asthma	4.9e-05	0.000146	CcSEcCtD
Leflunomide—Myalgia—Methylprednisolone—asthma	4.9e-05	0.000146	CcSEcCtD
Leflunomide—Arthralgia—Methylprednisolone—asthma	4.9e-05	0.000146	CcSEcCtD
Leflunomide—Eye disorder—Prednisone—asthma	4.89e-05	0.000145	CcSEcCtD
Leflunomide—DHODH—Metabolism—PTEN—asthma	4.89e-05	0.000474	CbGpPWpGaD
Leflunomide—Anxiety—Methylprednisolone—asthma	4.88e-05	0.000145	CcSEcCtD
Leflunomide—Tachycardia—Hydrocortisone—asthma	4.88e-05	0.000145	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.87e-05	0.000145	CcSEcCtD
Leflunomide—Skin disorder—Hydrocortisone—asthma	4.86e-05	0.000144	CcSEcCtD
Leflunomide—Ill-defined disorder—Betamethasone—asthma	4.86e-05	0.000144	CcSEcCtD
Leflunomide—Ill-defined disorder—Dexamethasone—asthma	4.86e-05	0.000144	CcSEcCtD
Leflunomide—Discomfort—Triamcinolone—asthma	4.85e-05	0.000144	CcSEcCtD
Leflunomide—Discomfort—Methylprednisolone—asthma	4.84e-05	0.000144	CcSEcCtD
Leflunomide—Hyperhidrosis—Hydrocortisone—asthma	4.83e-05	0.000144	CcSEcCtD
Leflunomide—Dry mouth—Triamcinolone—asthma	4.8e-05	0.000143	CcSEcCtD
Leflunomide—PTK2B—Immune System—ITPR1—asthma	4.79e-05	0.000465	CbGpPWpGaD
Leflunomide—Angioedema—Dexamethasone—asthma	4.78e-05	0.000142	CcSEcCtD
Leflunomide—Angioedema—Betamethasone—asthma	4.78e-05	0.000142	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCR3—asthma	4.78e-05	0.000463	CbGpPWpGaD
Leflunomide—Anorexia—Hydrocortisone—asthma	4.76e-05	0.000142	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—asthma	4.75e-05	0.000461	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ARG1—asthma	4.75e-05	0.000461	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTM1—asthma	4.75e-05	0.000461	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DQB1—asthma	4.74e-05	0.00046	CbGpPWpGaD
Leflunomide—Immune system disorder—Prednisone—asthma	4.73e-05	0.00014	CcSEcCtD
Leflunomide—Malaise—Betamethasone—asthma	4.72e-05	0.00014	CcSEcCtD
Leflunomide—Malaise—Dexamethasone—asthma	4.72e-05	0.00014	CcSEcCtD
Leflunomide—Anaphylactic shock—Triamcinolone—asthma	4.71e-05	0.00014	CcSEcCtD
Leflunomide—Vertigo—Dexamethasone—asthma	4.7e-05	0.00014	CcSEcCtD
Leflunomide—Vertigo—Betamethasone—asthma	4.7e-05	0.00014	CcSEcCtD
Leflunomide—Anaphylactic shock—Methylprednisolone—asthma	4.7e-05	0.00014	CcSEcCtD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTM1—asthma	4.69e-05	0.000455	CbGpPWpGaD
Leflunomide—Arrhythmia—Prednisone—asthma	4.68e-05	0.000139	CcSEcCtD
Leflunomide—Infection—Triamcinolone—asthma	4.68e-05	0.000139	CcSEcCtD
Leflunomide—Hypotension—Hydrocortisone—asthma	4.67e-05	0.000139	CcSEcCtD
Leflunomide—Infection—Methylprednisolone—asthma	4.67e-05	0.000139	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—asthma	4.66e-05	0.000452	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—asthma	4.66e-05	0.000452	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPY—asthma	4.65e-05	0.000452	CbGpPWpGaD
Leflunomide—Insomnia—Prednisolone—asthma	4.63e-05	0.000138	CcSEcCtD
Leflunomide—Alopecia—Prednisone—asthma	4.63e-05	0.000137	CcSEcCtD
Leflunomide—Nervous system disorder—Methylprednisolone—asthma	4.61e-05	0.000137	CcSEcCtD
Leflunomide—Paraesthesia—Prednisolone—asthma	4.6e-05	0.000137	CcSEcCtD
Leflunomide—Tachycardia—Triamcinolone—asthma	4.59e-05	0.000136	CcSEcCtD
Leflunomide—Mental disorder—Prednisone—asthma	4.59e-05	0.000136	CcSEcCtD
Leflunomide—Tachycardia—Methylprednisolone—asthma	4.58e-05	0.000136	CcSEcCtD
Leflunomide—PTK2B—Immune System—CD86—asthma	4.56e-05	0.000443	CbGpPWpGaD
Leflunomide—Skin disorder—Methylprednisolone—asthma	4.56e-05	0.000136	CcSEcCtD
Leflunomide—Malnutrition—Prednisone—asthma	4.56e-05	0.000135	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Hydrocortisone—asthma	4.55e-05	0.000135	CcSEcCtD
Leflunomide—Hyperhidrosis—Triamcinolone—asthma	4.55e-05	0.000135	CcSEcCtD
Leflunomide—Hyperhidrosis—Methylprednisolone—asthma	4.54e-05	0.000135	CcSEcCtD
Leflunomide—Insomnia—Hydrocortisone—asthma	4.52e-05	0.000134	CcSEcCtD
Leflunomide—Hypertension—Dexamethasone—asthma	4.52e-05	0.000134	CcSEcCtD
Leflunomide—Hypertension—Betamethasone—asthma	4.52e-05	0.000134	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL18—asthma	4.49e-05	0.000436	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AGTR2—asthma	4.49e-05	0.000436	CbGpPWpGaD
Leflunomide—Paraesthesia—Hydrocortisone—asthma	4.49e-05	0.000133	CcSEcCtD
Leflunomide—PTK2B—Immune System—CD40LG—asthma	4.48e-05	0.000434	CbGpPWpGaD
Leflunomide—Myalgia—Dexamethasone—asthma	4.46e-05	0.000132	CcSEcCtD
Leflunomide—Myalgia—Betamethasone—asthma	4.46e-05	0.000132	CcSEcCtD
Leflunomide—Anxiety—Betamethasone—asthma	4.44e-05	0.000132	CcSEcCtD
Leflunomide—Anxiety—Dexamethasone—asthma	4.44e-05	0.000132	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—asthma	4.44e-05	0.000431	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—asthma	4.44e-05	0.000431	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD8A—asthma	4.43e-05	0.000429	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CSF2—asthma	4.43e-05	0.000429	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTP1—asthma	4.42e-05	0.000429	CbGpPWpGaD
Leflunomide—Discomfort—Betamethasone—asthma	4.4e-05	0.000131	CcSEcCtD
Leflunomide—Discomfort—Dexamethasone—asthma	4.4e-05	0.000131	CcSEcCtD
Leflunomide—Dyspepsia—Hydrocortisone—asthma	4.4e-05	0.000131	CcSEcCtD
Leflunomide—Hypotension—Methylprednisolone—asthma	4.39e-05	0.00013	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ADCY2—asthma	4.39e-05	0.000426	CbGpPWpGaD
Leflunomide—Pain—Prednisolone—asthma	4.38e-05	0.00013	CcSEcCtD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTP1—asthma	4.36e-05	0.000423	CbGpPWpGaD
Leflunomide—Decreased appetite—Hydrocortisone—asthma	4.35e-05	0.000129	CcSEcCtD
Leflunomide—PTK2B—Immune System—AGER—asthma	4.32e-05	0.000419	CbGpPWpGaD
Leflunomide—Gastrointestinal disorder—Hydrocortisone—asthma	4.32e-05	0.000128	CcSEcCtD
Leflunomide—Fatigue—Hydrocortisone—asthma	4.31e-05	0.000128	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—EDNRB—asthma	4.3e-05	0.000417	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALDH7A1—asthma	4.3e-05	0.000417	CbGpPWpGaD
Leflunomide—Vision blurred—Prednisone—asthma	4.29e-05	0.000128	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Triamcinolone—asthma	4.29e-05	0.000127	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Methylprednisolone—asthma	4.28e-05	0.000127	CcSEcCtD
Leflunomide—Pain—Hydrocortisone—asthma	4.27e-05	0.000127	CcSEcCtD
Leflunomide—Anaphylactic shock—Betamethasone—asthma	4.27e-05	0.000127	CcSEcCtD
Leflunomide—Anaphylactic shock—Dexamethasone—asthma	4.27e-05	0.000127	CcSEcCtD
Leflunomide—Insomnia—Triamcinolone—asthma	4.26e-05	0.000126	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—TAC1—asthma	4.26e-05	0.000413	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPS—asthma	4.26e-05	0.000413	CbGpPWpGaD
Leflunomide—Insomnia—Methylprednisolone—asthma	4.25e-05	0.000126	CcSEcCtD
Leflunomide—Infection—Dexamethasone—asthma	4.24e-05	0.000126	CcSEcCtD
Leflunomide—Infection—Betamethasone—asthma	4.24e-05	0.000126	CcSEcCtD
Leflunomide—Ill-defined disorder—Prednisone—asthma	4.23e-05	0.000126	CcSEcCtD
Leflunomide—Paraesthesia—Triamcinolone—asthma	4.23e-05	0.000126	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisolone—asthma	4.22e-05	0.000125	CcSEcCtD
Leflunomide—Paraesthesia—Methylprednisolone—asthma	4.22e-05	0.000125	CcSEcCtD
Leflunomide—Anaemia—Prednisone—asthma	4.21e-05	0.000125	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—asthma	4.21e-05	0.000408	CbGpPWpGaD
Leflunomide—Dyspnoea—Triamcinolone—asthma	4.2e-05	0.000125	CcSEcCtD
Leflunomide—Nervous system disorder—Betamethasone—asthma	4.19e-05	0.000124	CcSEcCtD
Leflunomide—Nervous system disorder—Dexamethasone—asthma	4.19e-05	0.000124	CcSEcCtD
Leflunomide—Thrombocytopenia—Dexamethasone—asthma	4.18e-05	0.000124	CcSEcCtD
Leflunomide—Thrombocytopenia—Betamethasone—asthma	4.18e-05	0.000124	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CXCR3—asthma	4.17e-05	0.000405	CbGpPWpGaD
Leflunomide—Tachycardia—Betamethasone—asthma	4.17e-05	0.000124	CcSEcCtD
Leflunomide—Tachycardia—Dexamethasone—asthma	4.17e-05	0.000124	CcSEcCtD
Leflunomide—Angioedema—Prednisone—asthma	4.16e-05	0.000124	CcSEcCtD
Leflunomide—Dyspepsia—Triamcinolone—asthma	4.14e-05	0.000123	CcSEcCtD
Leflunomide—Dyspepsia—Methylprednisolone—asthma	4.13e-05	0.000123	CcSEcCtD
Leflunomide—Hyperhidrosis—Betamethasone—asthma	4.13e-05	0.000123	CcSEcCtD
Leflunomide—Hyperhidrosis—Dexamethasone—asthma	4.13e-05	0.000123	CcSEcCtD
Leflunomide—PTK2B—Immune System—PPP2CA—asthma	4.12e-05	0.0004	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ARG2—asthma	4.12e-05	0.0004	CbGpPWpGaD
Leflunomide—Feeling abnormal—Hydrocortisone—asthma	4.12e-05	0.000122	CcSEcCtD
Leflunomide—Malaise—Prednisone—asthma	4.11e-05	0.000122	CcSEcCtD
Leflunomide—Vertigo—Prednisone—asthma	4.09e-05	0.000122	CcSEcCtD
Leflunomide—Gastrointestinal pain—Hydrocortisone—asthma	4.09e-05	0.000121	CcSEcCtD
Leflunomide—Anorexia—Betamethasone—asthma	4.07e-05	0.000121	CcSEcCtD
Leflunomide—Anorexia—Dexamethasone—asthma	4.07e-05	0.000121	CcSEcCtD
Leflunomide—Urticaria—Prednisolone—asthma	4.07e-05	0.000121	CcSEcCtD
Leflunomide—CYP1A2—Biological oxidations—GSTM1—asthma	4.06e-05	0.000394	CbGpPWpGaD
Leflunomide—Fatigue—Triamcinolone—asthma	4.06e-05	0.000121	CcSEcCtD
Leflunomide—Fatigue—Methylprednisolone—asthma	4.05e-05	0.00012	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CYBA—asthma	4.04e-05	0.000392	CbGpPWpGaD
Leflunomide—Pain—Triamcinolone—asthma	4.03e-05	0.00012	CcSEcCtD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTM1—asthma	4e-05	0.000389	CbGpPWpGaD
Leflunomide—Hypotension—Dexamethasone—asthma	3.99e-05	0.000119	CcSEcCtD
Leflunomide—Hypotension—Betamethasone—asthma	3.99e-05	0.000119	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL2RA—asthma	3.99e-05	0.000387	CbGpPWpGaD
Leflunomide—Urticaria—Hydrocortisone—asthma	3.97e-05	0.000118	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PARP1—asthma	3.96e-05	0.000384	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL5—asthma	3.96e-05	0.000384	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—C3—asthma	3.96e-05	0.000384	CbGpPWpGaD
Leflunomide—Abdominal pain—Hydrocortisone—asthma	3.95e-05	0.000117	CcSEcCtD
Leflunomide—Body temperature increased—Hydrocortisone—asthma	3.95e-05	0.000117	CcSEcCtD
Leflunomide—Hypertension—Prednisone—asthma	3.93e-05	0.000117	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Dexamethasone—asthma	3.89e-05	0.000116	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Betamethasone—asthma	3.89e-05	0.000116	CcSEcCtD
Leflunomide—Arthralgia—Prednisone—asthma	3.88e-05	0.000115	CcSEcCtD
Leflunomide—Myalgia—Prednisone—asthma	3.88e-05	0.000115	CcSEcCtD
Leflunomide—Feeling abnormal—Triamcinolone—asthma	3.88e-05	0.000115	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	3.87e-05	0.000376	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	3.87e-05	0.000376	CbGpPWpGaD
Leflunomide—Feeling abnormal—Methylprednisolone—asthma	3.87e-05	0.000115	CcSEcCtD
Leflunomide—Anxiety—Prednisone—asthma	3.87e-05	0.000115	CcSEcCtD
Leflunomide—Insomnia—Betamethasone—asthma	3.86e-05	0.000115	CcSEcCtD
Leflunomide—Insomnia—Dexamethasone—asthma	3.86e-05	0.000115	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.85e-05	0.000114	CcSEcCtD
Leflunomide—PTK2B—Immune System—PDGFB—asthma	3.85e-05	0.000374	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Methylprednisolone—asthma	3.84e-05	0.000114	CcSEcCtD
Leflunomide—Paraesthesia—Dexamethasone—asthma	3.83e-05	0.000114	CcSEcCtD
Leflunomide—Paraesthesia—Betamethasone—asthma	3.83e-05	0.000114	CcSEcCtD
Leflunomide—Discomfort—Prednisone—asthma	3.83e-05	0.000114	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—BDKRB2—asthma	3.82e-05	0.000371	CbGpPWpGaD
Leflunomide—Hypersensitivity—Prednisolone—asthma	3.77e-05	0.000112	CcSEcCtD
Leflunomide—PTK2B—Immune System—CRP—asthma	3.76e-05	0.000365	CbGpPWpGaD
Leflunomide—Dyspepsia—Dexamethasone—asthma	3.76e-05	0.000112	CcSEcCtD
Leflunomide—Dyspepsia—Betamethasone—asthma	3.76e-05	0.000112	CcSEcCtD
Leflunomide—Urticaria—Triamcinolone—asthma	3.74e-05	0.000111	CcSEcCtD
Leflunomide—Urticaria—Methylprednisolone—asthma	3.73e-05	0.000111	CcSEcCtD
Leflunomide—Body temperature increased—Triamcinolone—asthma	3.72e-05	0.000111	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisone—asthma	3.72e-05	0.00011	CcSEcCtD
Leflunomide—Abdominal pain—Methylprednisolone—asthma	3.71e-05	0.00011	CcSEcCtD
Leflunomide—Decreased appetite—Dexamethasone—asthma	3.71e-05	0.00011	CcSEcCtD
Leflunomide—Decreased appetite—Betamethasone—asthma	3.71e-05	0.00011	CcSEcCtD
Leflunomide—Infection—Prednisone—asthma	3.69e-05	0.00011	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—ADCY2—asthma	3.69e-05	0.000359	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	3.69e-05	0.000359	CbGpPWpGaD
Leflunomide—Gastrointestinal disorder—Dexamethasone—asthma	3.69e-05	0.00011	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Betamethasone—asthma	3.69e-05	0.00011	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—HMOX1—asthma	3.69e-05	0.000358	CbGpPWpGaD
Leflunomide—Hypersensitivity—Hydrocortisone—asthma	3.68e-05	0.000109	CcSEcCtD
Leflunomide—Fatigue—Betamethasone—asthma	3.68e-05	0.000109	CcSEcCtD
Leflunomide—Fatigue—Dexamethasone—asthma	3.68e-05	0.000109	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—IL3—asthma	3.68e-05	0.000357	CbGpPWpGaD
Leflunomide—Pain—Betamethasone—asthma	3.65e-05	0.000108	CcSEcCtD
Leflunomide—Pain—Dexamethasone—asthma	3.65e-05	0.000108	CcSEcCtD
Leflunomide—Nervous system disorder—Prednisone—asthma	3.65e-05	0.000108	CcSEcCtD
Leflunomide—Tachycardia—Prednisone—asthma	3.63e-05	0.000108	CcSEcCtD
Leflunomide—Skin disorder—Prednisone—asthma	3.61e-05	0.000107	CcSEcCtD
Leflunomide—PTK2B—Immune System—TLR4—asthma	3.61e-05	0.00035	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DRB1—asthma	3.6e-05	0.00035	CbGpPWpGaD
Leflunomide—Hyperhidrosis—Prednisone—asthma	3.6e-05	0.000107	CcSEcCtD
Leflunomide—Asthenia—Hydrocortisone—asthma	3.59e-05	0.000107	CcSEcCtD
Leflunomide—Anorexia—Prednisone—asthma	3.55e-05	0.000105	CcSEcCtD
Leflunomide—Pruritus—Hydrocortisone—asthma	3.54e-05	0.000105	CcSEcCtD
Leflunomide—Feeling abnormal—Betamethasone—asthma	3.52e-05	0.000105	CcSEcCtD
Leflunomide—Feeling abnormal—Dexamethasone—asthma	3.52e-05	0.000105	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dexamethasone—asthma	3.49e-05	0.000104	CcSEcCtD
Leflunomide—Gastrointestinal pain—Betamethasone—asthma	3.49e-05	0.000104	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—KNG1—asthma	3.47e-05	0.000337	CbGpPWpGaD
Leflunomide—Hypersensitivity—Triamcinolone—asthma	3.47e-05	0.000103	CcSEcCtD
Leflunomide—Hypersensitivity—Methylprednisolone—asthma	3.46e-05	0.000103	CcSEcCtD
Leflunomide—PTK2B—Immune System—ICAM1—asthma	3.46e-05	0.000336	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AGTR1—asthma	3.45e-05	0.000335	CbGpPWpGaD
Leflunomide—Diarrhoea—Hydrocortisone—asthma	3.42e-05	0.000102	CcSEcCtD
Leflunomide—ABCG2—Metabolism—ALOX15—asthma	3.41e-05	0.000331	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALOX5AP—asthma	3.41e-05	0.000331	CbGpPWpGaD
Leflunomide—Urticaria—Betamethasone—asthma	3.39e-05	0.000101	CcSEcCtD
Leflunomide—Urticaria—Dexamethasone—asthma	3.39e-05	0.000101	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Prednisone—asthma	3.39e-05	0.000101	CcSEcCtD
Leflunomide—Dizziness—Prednisolone—asthma	3.38e-05	0.000101	CcSEcCtD
Leflunomide—Asthenia—Triamcinolone—asthma	3.38e-05	0.0001	CcSEcCtD
Leflunomide—Abdominal pain—Betamethasone—asthma	3.38e-05	0.0001	CcSEcCtD
Leflunomide—Body temperature increased—Betamethasone—asthma	3.38e-05	0.0001	CcSEcCtD
Leflunomide—Body temperature increased—Dexamethasone—asthma	3.38e-05	0.0001	CcSEcCtD
Leflunomide—Abdominal pain—Dexamethasone—asthma	3.38e-05	0.0001	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CXCL10—asthma	3.37e-05	0.000327	CbGpPWpGaD
Leflunomide—Asthenia—Methylprednisolone—asthma	3.37e-05	0.0001	CcSEcCtD
Leflunomide—Insomnia—Prednisone—asthma	3.36e-05	9.99e-05	CcSEcCtD
Leflunomide—CYP2C9—Biological oxidations—POMC—asthma	3.36e-05	0.000326	CbGpPWpGaD
Leflunomide—Paraesthesia—Prednisone—asthma	3.34e-05	9.92e-05	CcSEcCtD
Leflunomide—Pruritus—Triamcinolone—asthma	3.33e-05	9.89e-05	CcSEcCtD
Leflunomide—Pruritus—Methylprednisolone—asthma	3.32e-05	9.87e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—NTRK1—asthma	3.31e-05	0.000321	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	3.31e-05	0.000321	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—asthma	3.31e-05	0.000321	CbGpPWpGaD
Leflunomide—Dizziness—Hydrocortisone—asthma	3.31e-05	9.82e-05	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	3.29e-05	0.00032	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB2—asthma	3.28e-05	0.000318	CbGpPWpGaD
Leflunomide—Dyspepsia—Prednisone—asthma	3.27e-05	9.73e-05	CcSEcCtD
Leflunomide—ABCG2—Metabolism—CHAT—asthma	3.26e-05	0.000316	CbGpPWpGaD
Leflunomide—Decreased appetite—Prednisone—asthma	3.23e-05	9.6e-05	CcSEcCtD
Leflunomide—Rash—Prednisolone—asthma	3.23e-05	9.59e-05	CcSEcCtD
Leflunomide—Dermatitis—Prednisolone—asthma	3.22e-05	9.58e-05	CcSEcCtD
Leflunomide—Diarrhoea—Methylprednisolone—asthma	3.21e-05	9.55e-05	CcSEcCtD
Leflunomide—Fatigue—Prednisone—asthma	3.21e-05	9.53e-05	CcSEcCtD
Leflunomide—Headache—Prednisolone—asthma	3.21e-05	9.52e-05	CcSEcCtD
Leflunomide—Constipation—Prednisone—asthma	3.18e-05	9.45e-05	CcSEcCtD
Leflunomide—Vomiting—Hydrocortisone—asthma	3.18e-05	9.44e-05	CcSEcCtD
Leflunomide—CYP2C9—Metabolism—LTC4S—asthma	3.17e-05	0.000307	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—asthma	3.16e-05	0.000306	CbGpPWpGaD
Leflunomide—Rash—Hydrocortisone—asthma	3.15e-05	9.36e-05	CcSEcCtD
Leflunomide—Dermatitis—Hydrocortisone—asthma	3.15e-05	9.35e-05	CcSEcCtD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	3.14e-05	0.000305	CbGpPWpGaD
Leflunomide—Headache—Hydrocortisone—asthma	3.13e-05	9.3e-05	CcSEcCtD
Leflunomide—Dizziness—Triamcinolone—asthma	3.11e-05	9.25e-05	CcSEcCtD
Leflunomide—Dizziness—Methylprednisolone—asthma	3.11e-05	9.23e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—ITPR1—asthma	3.1e-05	0.000301	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6R—asthma	3.09e-05	0.000299	CbGpPWpGaD
Leflunomide—Feeling abnormal—Prednisone—asthma	3.06e-05	9.1e-05	CcSEcCtD
Leflunomide—Asthenia—Betamethasone—asthma	3.06e-05	9.1e-05	CcSEcCtD
Leflunomide—Asthenia—Dexamethasone—asthma	3.06e-05	9.1e-05	CcSEcCtD
Leflunomide—Gastrointestinal pain—Prednisone—asthma	3.04e-05	9.03e-05	CcSEcCtD
Leflunomide—Nausea—Prednisolone—asthma	3.04e-05	9.03e-05	CcSEcCtD
Leflunomide—Pruritus—Dexamethasone—asthma	3.02e-05	8.98e-05	CcSEcCtD
Leflunomide—Pruritus—Betamethasone—asthma	3.02e-05	8.98e-05	CcSEcCtD
Leflunomide—Vomiting—Triamcinolone—asthma	2.99e-05	8.89e-05	CcSEcCtD
Leflunomide—Vomiting—Methylprednisolone—asthma	2.99e-05	8.87e-05	CcSEcCtD
Leflunomide—Nausea—Hydrocortisone—asthma	2.97e-05	8.82e-05	CcSEcCtD
Leflunomide—Rash—Triamcinolone—asthma	2.97e-05	8.82e-05	CcSEcCtD
Leflunomide—Dermatitis—Triamcinolone—asthma	2.97e-05	8.81e-05	CcSEcCtD
Leflunomide—Rash—Methylprednisolone—asthma	2.96e-05	8.8e-05	CcSEcCtD
Leflunomide—Dermatitis—Methylprednisolone—asthma	2.96e-05	8.79e-05	CcSEcCtD
Leflunomide—Urticaria—Prednisone—asthma	2.95e-05	8.78e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CD86—asthma	2.95e-05	0.000286	CbGpPWpGaD
Leflunomide—Headache—Triamcinolone—asthma	2.95e-05	8.76e-05	CcSEcCtD
Leflunomide—Headache—Methylprednisolone—asthma	2.94e-05	8.74e-05	CcSEcCtD
Leflunomide—Body temperature increased—Prednisone—asthma	2.94e-05	8.73e-05	CcSEcCtD
Leflunomide—Abdominal pain—Prednisone—asthma	2.94e-05	8.73e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—EDN1—asthma	2.93e-05	0.000284	CbGpPWpGaD
Leflunomide—Diarrhoea—Dexamethasone—asthma	2.92e-05	8.68e-05	CcSEcCtD
Leflunomide—Diarrhoea—Betamethasone—asthma	2.92e-05	8.68e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCL5—asthma	2.9e-05	0.000282	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALOX5—asthma	2.9e-05	0.000282	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLA2G4A—asthma	2.89e-05	0.000281	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—POMC—asthma	2.87e-05	0.000279	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CSF2—asthma	2.86e-05	0.000278	CbGpPWpGaD
Leflunomide—Dizziness—Dexamethasone—asthma	2.82e-05	8.39e-05	CcSEcCtD
Leflunomide—Dizziness—Betamethasone—asthma	2.82e-05	8.39e-05	CcSEcCtD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.81e-05	0.000273	CbGpPWpGaD
Leflunomide—Nausea—Triamcinolone—asthma	2.8e-05	8.3e-05	CcSEcCtD
Leflunomide—Nausea—Methylprednisolone—asthma	2.79e-05	8.29e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—SMAD3—asthma	2.79e-05	0.00027	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CARM1—asthma	2.77e-05	0.000269	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LTA4H—asthma	2.75e-05	0.000267	CbGpPWpGaD
Leflunomide—Hypersensitivity—Prednisone—asthma	2.74e-05	8.14e-05	CcSEcCtD
Leflunomide—ABCG2—Metabolism—DCN—asthma	2.73e-05	0.000265	CbGpPWpGaD
Leflunomide—Vomiting—Betamethasone—asthma	2.72e-05	8.07e-05	CcSEcCtD
Leflunomide—Vomiting—Dexamethasone—asthma	2.72e-05	8.07e-05	CcSEcCtD
Leflunomide—CYP1A2—Metabolism—LTC4S—asthma	2.71e-05	0.000263	CbGpPWpGaD
Leflunomide—Rash—Betamethasone—asthma	2.69e-05	8e-05	CcSEcCtD
Leflunomide—Rash—Dexamethasone—asthma	2.69e-05	8e-05	CcSEcCtD
Leflunomide—Dermatitis—Betamethasone—asthma	2.69e-05	7.99e-05	CcSEcCtD
Leflunomide—Dermatitis—Dexamethasone—asthma	2.69e-05	7.99e-05	CcSEcCtD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—asthma	2.68e-05	0.00026	CbGpPWpGaD
Leflunomide—Headache—Betamethasone—asthma	2.68e-05	7.95e-05	CcSEcCtD
Leflunomide—Headache—Dexamethasone—asthma	2.68e-05	7.95e-05	CcSEcCtD
Leflunomide—Asthenia—Prednisone—asthma	2.67e-05	7.93e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—PPP2CA—asthma	2.67e-05	0.000259	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BCL2—asthma	2.66e-05	0.000258	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALDH2—asthma	2.66e-05	0.000258	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—asthma	2.63e-05	0.000255	CbGpPWpGaD
Leflunomide—Pruritus—Prednisone—asthma	2.63e-05	7.82e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—CCR5—asthma	2.62e-05	0.000254	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2RA—asthma	2.58e-05	0.00025	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—C3—asthma	2.56e-05	0.000248	CbGpPWpGaD
Leflunomide—Diarrhoea—Prednisone—asthma	2.54e-05	7.56e-05	CcSEcCtD
Leflunomide—PTK2B—Immune System—CD4—asthma	2.54e-05	0.000247	CbGpPWpGaD
Leflunomide—Nausea—Dexamethasone—asthma	2.54e-05	7.54e-05	CcSEcCtD
Leflunomide—Nausea—Betamethasone—asthma	2.54e-05	7.54e-05	CcSEcCtD
Leflunomide—ABCG2—Metabolism—GSTT1—asthma	2.53e-05	0.000245	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDGFB—asthma	2.49e-05	0.000242	CbGpPWpGaD
Leflunomide—Dizziness—Prednisone—asthma	2.46e-05	7.31e-05	CcSEcCtD
Leflunomide—CYP2C9—Metabolism—ARG1—asthma	2.4e-05	0.000233	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—asthma	2.38e-05	0.000231	CbGpPWpGaD
Leflunomide—Vomiting—Prednisone—asthma	2.36e-05	7.02e-05	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL1B—asthma	2.35e-05	0.000228	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LTA4H—asthma	2.35e-05	0.000228	CbGpPWpGaD
Leflunomide—Rash—Prednisone—asthma	2.35e-05	6.97e-05	CcSEcCtD
Leflunomide—Dermatitis—Prednisone—asthma	2.34e-05	6.96e-05	CcSEcCtD
Leflunomide—PTK2B—Immune System—IL2—asthma	2.34e-05	0.000227	CbGpPWpGaD
Leflunomide—Headache—Prednisone—asthma	2.33e-05	6.92e-05	CcSEcCtD
Leflunomide—PTK2B—Signaling Pathways—FN1—asthma	2.25e-05	0.000218	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—asthma	2.21e-05	0.000215	CbGpPWpGaD
Leflunomide—Nausea—Prednisone—asthma	2.21e-05	6.56e-05	CcSEcCtD
Leflunomide—PTK2B—Immune System—PTEN—asthma	2.2e-05	0.000214	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDH7A1—asthma	2.17e-05	0.000211	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NQO1—asthma	2.1e-05	0.000204	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ARG2—asthma	2.08e-05	0.000202	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ADCY2—asthma	2.05e-05	0.000199	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ARG1—asthma	2.05e-05	0.000199	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—POMC—asthma	2.05e-05	0.000198	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL2—asthma	2e-05	0.000194	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6R—asthma	2e-05	0.000194	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—STAT3—asthma	1.97e-05	0.000191	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SERPINE1—asthma	1.87e-05	0.000181	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDH7A1—asthma	1.86e-05	0.00018	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.82e-05	0.000177	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RHOA—asthma	1.8e-05	0.000175	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—EGFR—asthma	1.79e-05	0.000174	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—asthma	1.78e-05	0.000173	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ARG2—asthma	1.78e-05	0.000173	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTP1—asthma	1.75e-05	0.00017	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—asthma	1.73e-05	0.000168	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALOX5AP—asthma	1.72e-05	0.000167	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALOX15—asthma	1.72e-05	0.000167	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ITPR1—asthma	1.72e-05	0.000167	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAT—asthma	1.7e-05	0.000165	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CHAT—asthma	1.65e-05	0.00016	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLA2G4A—asthma	1.61e-05	0.000156	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTM1—asthma	1.61e-05	0.000156	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL8—asthma	1.58e-05	0.000154	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.56e-05	0.000151	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—asthma	1.51e-05	0.000147	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPP2CA—asthma	1.48e-05	0.000144	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALOX15—asthma	1.47e-05	0.000143	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALOX5AP—asthma	1.47e-05	0.000143	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALOX5—asthma	1.47e-05	0.000142	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MMP9—asthma	1.43e-05	0.000139	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PTEN—asthma	1.42e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CHAT—asthma	1.41e-05	0.000136	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CARM1—asthma	1.4e-05	0.000136	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DCN—asthma	1.38e-05	0.000134	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—asthma	1.37e-05	0.000133	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALDH2—asthma	1.34e-05	0.00013	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	1.29e-05	0.000125	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—asthma	1.29e-05	0.000125	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTT1—asthma	1.28e-05	0.000124	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT3—asthma	1.27e-05	0.000123	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALOX5—asthma	1.25e-05	0.000122	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CARM1—asthma	1.2e-05	0.000116	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—asthma	1.18e-05	0.000114	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DCN—asthma	1.18e-05	0.000114	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	1.18e-05	0.000114	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EGFR—asthma	1.16e-05	0.000112	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALDH2—asthma	1.15e-05	0.000111	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—POMC—asthma	1.14e-05	0.00011	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	1.1e-05	0.000107	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTT1—asthma	1.09e-05	0.000106	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NQO1—asthma	1.06e-05	0.000103	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ADCY2—asthma	1.04e-05	0.000101	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—asthma	1.04e-05	0.000101	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.03e-05	9.98e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	1e-05	9.75e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—asthma	9.92e-06	9.62e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—asthma	9.07e-06	8.8e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NQO1—asthma	9.06e-06	8.79e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	8.97e-06	8.71e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—asthma	8.89e-06	8.62e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ADCY2—asthma	8.87e-06	8.6e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTP1—asthma	8.84e-06	8.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.79e-06	8.53e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—asthma	8.72e-06	8.46e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ITPR1—asthma	8.7e-06	8.44e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAT—asthma	8.6e-06	8.35e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLA2G4A—asthma	8.13e-06	7.89e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTM1—asthma	8.13e-06	7.89e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTEN—asthma	7.91e-06	7.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	7.67e-06	7.44e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTP1—asthma	7.56e-06	7.33e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPP2CA—asthma	7.48e-06	7.26e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—asthma	7.45e-06	7.23e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ITPR1—asthma	7.44e-06	7.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAT—asthma	7.35e-06	7.14e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLA2G4A—asthma	6.94e-06	6.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTM1—asthma	6.94e-06	6.74e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPP2CA—asthma	6.4e-06	6.21e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—POMC—asthma	5.74e-06	5.57e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—asthma	5.24e-06	5.08e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—asthma	5.01e-06	4.86e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—POMC—asthma	4.91e-06	4.76e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—asthma	4.58e-06	4.45e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—asthma	4.47e-06	4.34e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—asthma	4.28e-06	4.15e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTEN—asthma	4e-06	3.88e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—asthma	3.91e-06	3.8e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTEN—asthma	3.41e-06	3.31e-05	CbGpPWpGaD
